Simultaneous Analysis of Zofenopril and Its Active Metabolite Zofenoprilat in Human Plasma by LC–ESI-MS Using Pre-Column Derivatization with p-Bromophenacyl Bromide
- 151 Downloads
Zofenoprilat is an active metabolite of zofenopril, which is very unstable in plasma because of oxidative degradation of its thiol group. In this method, p-bromophenacyl bromide was used as derivatization reagent, immediately after plasma separation, to react with the free thiol group of zofenoprilat and form the derivative zofenoprilat-p-BPB. After acidification with 50% acetic acid, the derivatized plasma samples were extracted with methyl tert-butyl ether and separated on a C18 column with 40:60 (v/v) 10 mM ammonium acetate buffer solution containing 0.1% formic acid–acetonitrile as mobile phase. Calibration plots were linear over the concentration range 1–500 ng mL−1 for zofenopril and 2–1,800 ng mL−1 for zofenoprilat. The method was successfully used to study the bioavailability of zofenopril calcium capsules relative to that of zofenopril calcium tablets in healthy Chinese volunteers.
KeywordsColumn liquid chromatography Mass spectrometry Zofenopril Zofenoprilat p-Bromophenacyl bromide Derivatization Pharmacokinetics
- 2.Evangelista S, Manzini S (2005) J Int Med Res 33(1):42–54Google Scholar
- 8.Marzo A, Dal Bo L, Mazzucchelli P, Monti NC, Tettamanti RA, Crivelli F, Uhr MR, Ismaili S, Giusti A (1999) Arzneim-Forsch 49(12):992–996Google Scholar
- 9.Marzo A, Dal Bo L, Mazzucchelli P, Monti NC, Crivelli F, Ismaili S, Giusti A, Uhr MR (2002) Arzneim-Forsch 52(4):233–242Google Scholar